GMAB - AbbVie Genmab blood cancer therapy endorsed in EU
2024-06-28 09:29:56 ET
More on AbbVie, Genmab, etc.
- AbbVie: 5 Reasons That Make A Buy Case
- AbbVie, Inc. (ABBV) Goldman Sachs 45th Annual Global Healthcare Conference (Transcript)
- AbbVie: Turnaround Lurking After The Correction Pain (Upgrade)
- AbbVie buys bowel disease drug developer Celsius for $250M
- Genmab, AbbVie win FDA nod for relapsed follicular lymphoma therapy